jd,
RE: <<Bill would be just lip service to issue of wider health care access and would be profit irrelevant to the health care
stocks. Just another ineffectual sham agency to accept constituent paperwork without transferring any governmental
money like medicare or effecting business environment at health care companies like FDA.>>
Why do you think it would be "profit irrelevant" to health care companies? I imagine it will include a broader version of the indemnity that they gave to Lilly[?] in the Homeland Security bill. Why not indemnify all pharmaceutical companies from being held liable for mistakes they might make? Their goal, after all, is to help people, to cure them, not to make them sick, and shouldn't they be given the benefit of the doubt given their noble goal? After all, think of the boost that would give to future drug research, think of the good that all these new drugs would do, think of how quickly they could come to market if the companies didn't have to think about the scumbag leech trial lawyers who are always grubbing for a buck at the expense of the real producers of the economy.
John Swift
Market Data 
Markets 
AI
